Anxiety and Depression Care Demand Rises

Why Is Demand for Anxiety and Depression Treatment Rising?

Anxiety disorders and depressive disorders are among the most common reasons people seek mental health care. NIMH data show that anxiety disorders affect a substantial share of U.S. adults each year, and major depression affects millions of adults and adolescents. At the same time, CDC data show that the share of adults receiving mental health treatment increased from 2019 to 2023, suggesting that more people are using medication, counseling or both.

The increase does not necessarily mean that mental illness is rising for one single reason. Greater screening in primary care, telehealth access, workplace mental health benefits, reduced stigma and lingering stressors from recent years may all contribute. For patients, the practical message is that symptoms such as persistent worry, panic attacks, loss of interest, sleep disruption, appetite changes and impaired concentration deserve medical attention when they interfere with daily life.

What Treatments Are Evidence-Based for Anxiety and Depression?

Cognitive behavioral therapy has strong evidence across anxiety disorders and depression, especially when patients can practice skills between sessions. For moderate to severe depression or anxiety, clinicians may consider medications such as selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. These medicines are not instant treatments; benefits often build over several weeks, and side effects, drug interactions and withdrawal planning should be discussed before stopping or switching therapy.

Newer and more specialized options are also expanding care for people who do not respond to first-line treatment. Transcranial magnetic stimulation is used for some patients with treatment-resistant depression, and esketamine nasal spray is FDA-approved for specific depression indications under medical supervision. These advances matter, but they do not replace careful diagnosis, suicide risk assessment, sleep and substance-use evaluation, and follow-up care.

How Should Patients Choose Safe Mental Health Care?

As mental health treatment options grow, quality control becomes more important. A safe care plan should include a clear diagnosis, discussion of treatment choices, screening for bipolar disorder before antidepressant treatment when appropriate, and a plan for monitoring symptoms. Standardized tools such as the PHQ-9 for depression or GAD-7 for anxiety can help track whether treatment is working, although they do not replace a clinical assessment.

Access remains a major challenge. Some patients face long waits, insurance barriers or a shortage of clinicians trained in evidence-based therapy. Digital tools and telehealth can help extend care, but they should be judged by clinical safeguards, privacy practices and whether they connect people to human support when symptoms worsen. Anyone with thoughts of self-harm, psychosis, severe agitation or inability to function should seek urgent professional help.